Jellyana Peraza
Appearances
DateMay 19, 2024BACKGROUND: The Montreal Classification (MC) captures the heterogeneity of Crohn's disease (CD). While the MC is an important tool for characterizing CD, its ascertainment for real-world studies requires manual chart review that is labor-intensive with limited scalability…Presenter
Speakers
Icahn School of Medicine at Mount Sinai- DateMay 18, 2024Approximately 20-30% of individuals with Crohn's disease (CD) experience a relatively mild disease course without progression. However, there is no widely accepted objective definition of mild CD. We aimed to identify endoscopic severity cut-offs that can be used to define mild non-progressive CD…
Presenter
Speakers
Icahn School of Medicine at Mount SinaiMassachusetts General Hospital 
DateMay 18, 2024SOCIETY: AGA This session highlights the latest research on novel prediction models in IBD as well as the role of the fecal microbiome and imaging in IBD…Moderators
University of California San FranciscoUniversite de MontrealSpeakers
Icahn School of Medicine at Mount Sinai Department of PediatricsCedars-Sinai Medical Center
